Comparison of Outcome of Trabeculectomy With Mitomycin C and Ahmed Valve Implantation for Uveitic Glaucoma.
10.3341/jkos.2010.51.4.575
- Author:
Joo Yeon KIM
1
;
Hyoung Sub SHIM
;
Hwang Ki KIM
;
Yong Ho SOHN
Author Information
1. Department of Ophthalmology, Konyang University, Kim's Eye Hospital, Myung-Gok Eye Research Institute, Seoul, Korea. yhsohn@konyang.ac.kr
- Publication Type:Original Article
- Keywords:
Ahmed valve implantation;
Trabeculectomy with mitomycin C;
Uveitic glaucoma
- MeSH:
Diabetes Mellitus;
Eye;
Glaucoma;
Glaucoma, Open-Angle;
Humans;
Intraocular Pressure;
Mitomycin;
Postoperative Period;
Retrospective Studies;
Trabeculectomy;
Uveitis
- From:Journal of the Korean Ophthalmological Society
2010;51(4):575-580
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To assess and compare the clinical outcomes of primary trabeculectomy with mitomycin C and Ahmed valve implantation for secondary open-angle glaucoma following uveitis. METHODS: This study was conducted retrospectively on 30 eyes of 25 patients with open-angle glaucoma secondary to uveitis that had undergone trabeculectomy with mitomycin C and 33 eyes of 24 patients that had undergone Ahmed valve implantation. The clinical outcome indicators used in this study were intraocular pressure (IOP), number of anti-glaucoma agents, surgical success rate and occurrence of complications. RESULTS: Mean IOP and surgical success rate in patients who had undergone trabeculectomy with mitomycin C after a 12 month postoperative period were 14.0+/-8.2 mmHg and 76.7%, respectively, while those of patients with Ahmed valve implantation were 13.2+/-7.7 mmHg and 81.8%. The data did not show clinical significance. There was greater risk of surgical failure in patients at a younger age and/or with diabetes mellitus in cases of having gone through trabeculectomy with mitomycin C. CONCLUSIONS: Both trabeculectomy with mitomycon C and Ahmed valve implantation can be considered as primary surgical treatments for patients with open-angle glaucoma secondary to uveitis. However, trabeculectomy with mitomycin C should only be applied to a limited extent in patients that are young and/or have diabetes mellitus.
